RIM
UTMD icon

Ranger Investment Management’s Utah Medical Products UTMD Stock Holding History

Ranger Investment Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-84,699
Closed -$5.21M – 92
2024
Q4 		$5.21M Sell
84,699
-1,855
-2% -$120K 0.33% 66
2024
Q3 		$5.79M Buy
86,554
+1,800
+2% +$122K 0.37% 60
2024
Q2 		$5.66M Buy
84,754
+4,305
+5% +$293K 0.39% 63
2024
Q1 		$5.72M Buy
80,449
+2,858
+4% +$214K 0.37% 66
2023
Q4 		$6.53M Buy
77,591
+3,180
+4% +$264K 0.4% 60
2023
Q3 		$6.4M Sell
74,411
-4,270
-5% -$394K 0.42% 61
2023
Q2 		$7.33M Buy
78,681
+6,156
+8% +$580K 0.44% 61
2023
Q1 		$6.87M Sell
72,525
-2,562
-3% -$235K 0.46% 53
2022
Q4 		$7.55M Buy
75,087
+1,515
+2% +$138K 0.56% 52
2022
Q3 		$6.28M Sell
73,572
-1,312
-2% -$116K 0.49% 55
2022
Q2 		$6.43M Buy
74,884
+1,774
+2% +$151K 0.49% 56
2022
Q1 		$6.57M Buy
73,110
+4,380
+6% +$403K 0.42% 59
2021
Q4 		$6.87M Buy
68,730
+11
+0% +$1.12K 0.38% 58
2021
Q3 		$6.38M Buy
68,719
+4,912
+8% +$434K 0.34% 61
2021
Q2 		$5.43M Buy
63,807
+8,245
+15% +$713K 0.28% 61
2021
Q1 		$4.81M Sell
55,562
-675
-1% -$59.4K 0.26% 69
2020
Q4 		$4.74M Sell
56,237
-9,474
-14% -$808K 0.25% 63
2020
Q3 		$5.25M Sell
65,711
-1,545
-2% -$128K 0.33% 58
2020
Q2 		$5.96M Buy
67,256
+1,395
+2% +$125K 0.41% 58
2020
Q1 		$6.19M Buy
65,861
+7,371
+13% +$685K 0.54% 50
2019
Q4 		$6.31M Sell
58,490
-1,585
-3% -$161K 0.42% 53
2019
Q3 		$5.76M Buy
60,075
+2,212
+4% +$206K 0.41% 57
2019
Q2 		$5.54M Buy
57,863
+2,327
+4% +$196K 0.38% 59
2019
Q1 		$4.9M Buy
55,536
+5,720
+11% +$503K 0.35% 60
2018
Q4 		$4.14M Buy
49,816
+5,512
+12% +$485K 0.34% 60
2018
Q3 		$4.17M Buy
44,304
+18,675
+73% +$1.78M 0.28% 58
2018
Q2 		$2.82M Buy
+25,629
New +$2.68M 0.2% 66

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Ranger Investment Management's UTMD Position: Q1 2025 in Review

Ranger Investment Management sold out of Utah Medical Products (UTMD) in Q1 2025, closing a stake of 84,699 shares — an estimated $5.21M sold.

Ranger Investment Management first reported a position in UTMD in Q2 2018 and held it in 27 quarters. The position peaked at $7.55M in Q4 2022. 109 funds tracked by Wall St. Rank hold UTMD as of Q1 2025.

  • Ranger Investment Management reported no remaining Utah Medical Products position as of Q1 2025 after selling out during the quarter.
  • Ranger Investment Management sold 84,699 Utah Medical Products shares in Q1 2025, an estimated $5.21M.
  • Ranger Investment Management first reported a position in Utah Medical Products in Q2 2018 and held it in 27 quarters.
  • Ranger Investment Management's Utah Medical Products position peaked at $7.55M in Q4 2022.
  • 109 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2025.

Based on Ranger Investment Management's 13F filing for Q1 2025, filed 15 May 2025.